Effect of non-steroidal anti-inflammatory drugs on colon carcinoma Caco-2 cell responsiveness to topoisomerase inhibitor drugs

British Journal of Cancer

Volumn 86, Issue 9, 2002, Pages 1501-1509

  Ricchi, P ^a,b   Di Matola, T ^a   Ruggiero, G ^a   Zanzi, D ^a   Apicella, A ^a   Di Palma, A ^a   Pensabene, M ^a   Pignata, S ^b   Zarrilli, R ^a   Acquaviva, A M ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Aspirin; Bcl 2; Cell cycle; Colon cancer; NS 398; Topoisomerase inhibitors

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2 INHIBITOR; DNA TOPOISOMERASE INHIBITOR; ETOPOSIDE; IRINOTECAN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN CACO 2; CHEMOPROPHYLAXIS; COLON CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; DRUG MECHANISM; DRUG SENSITIVITY; NONHUMAN; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; ASPIRIN; CACO-2 CELLS; CAMPTOTHECIN; CELL SURVIVAL; DNA TOPOISOMERASES; ENZYME INHIBITORS; ETOPOSIDE; HUMANS; NITROBENZENES; SULFONAMIDES;

EID: 18444395848     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600289     Document Type: Article

References (54)

1. A K-ras oncogene increases resistance to sulindac-induced apoptosis in rat enterocytes
2. Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis
3. Oncogenic transformation potentiates apoptosis, S-phase arrest and stress-kinase activation by etoposide
4. Antitumor activity of combined blockade of Epidermal Growth Factor receptor and protein kinase A
5. Anti-sense oligonucleotides directed against EGF-related growth factor enhance anti-proliferative effect of conventional anti-tumor drugs in human colon-cancer cells
6. IGF-II/IGF receptor pathway up-regulates COX-2 mRNA expression and PGE2 synthesis in Caco-2 human colon carcinoma cells
7. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma
8. Citotoxity of the anticancer agents cisplatin and taxol during cell proliferation and cell cycle
9. A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells
10. Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs)
11. Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: Enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma cell lines
12. Dexamethasone and etoposide induce apoptosis in rat thymocytes from different phases of the cell cycle
13. Apoptosis in cancer therapy: Crossing the threshold
14. G(1) phase-dependent expression of bcl-2 mRNA and protein correlates with chemoresistance of human cancer cells
15. Topoisomerase I-related parameters and camptothecin activity in the colon carcinoma cell lines from the National Cancer Institute Anticancer Screen
16. Neuroprotection by aspirin and sodium salicylate through blockade of NF-kB activation
17. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib
18. p53 status affects the rate of the onset but not the overall extent of doxorubicin-induced cell death in rat-1 fibroblasts constitutively expressing c-Myc
19. Cyclooxigenase-2 inhibitor induce apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer lines
20. KIP1 as a mechanism underlying NS398-induced growth inhibition in human lung cancer cells
21. Bcl-2 protein inhibits etoposide-induced apoptosis through its effect on events subsequent to topoisomerase II-induced DNA strand breaks and their repair
22. Bcl-2 gene family and the regulation of programmed cell death
23. Overexpression of bax gene sensitizes K562 erythroleukemia cells to apoptosis induced by selective chemotherapeutic agents
24. Salicylate-induced growth arrest is associated with inhibition of p70s6k and down-regulation of c-myc, cyclin D1, cyclin A, and proliferating cell nuclear antigen
25. Prevention by aspirin and its combination with alpha-difluoromethylornithine of azoxymethane-induced tumors, aberrant crypt foci and prostaglandin E2 levels in rat colon
26. Apoptosis may be either suppressed or enhanced with strategic combination of antineoplastic drugs or anti-IgM
27. Nonsteroidal anti-inflammatory drugs cause apoptosis and induce cyclooxygenases in chicken embryo fibroblasts
28. Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors
29. Inhibition of vascular smooth muscle cell proliferation by sodium salicylate mediated by up-regulation of p21(Waf1) and p27(Kip1)
30. Induction of p53-dependent and p53-independent cellular responses by topoisomerase 1 inhibitors
31. Apoptosis by death factor
32. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow citometry
33. Antitopoisomerase drug action and resistance
34. Mechanisms of cell killing by drugs that trap covalent complexes between DNA topoisomerases and DNA
35. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis
36. Effect of aspirin treatment on cell proliferation and differentiation of colon adenocarcinoma Caco-2 cells
37. Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer
38. Abrogation of an S-phase checkpoint and potentiation of camptothecin cytotoxicity by 7-hydroxystauroporine (UCN-01) in human cancer cell lines, possibly influenced by p53 function
39. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells
40. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells
41. Nonsteroidal anti-inflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: Effects on cell cycle and apoptosis
42. Phase I trial of sulindac plus 5-fluorouracil and levamisole: Potential adjuvant therapy for colon carcinoma
43. The effect of non-steirodal anti-inflammatory drugs on human colorectal cancer cell: Evidence of different mechanisms of action
44. Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines
45. BAX expression is associated with enhanced intracellular accumulation of paclitaxel: A novel role for BAX during chemotherapy-induced cell death
46. Bad partly reverses paclitaxel resistance in human ovarian cancer cells
47. Combinatorial chemoprevention of intestinal neoplasia
48. Synergistic inhibition of growth and induction of apoptosis by 8-chloro-cAMP and paclitaxel or cisplatin in human cancer cell
49. Apoptosis induced by X-irradiation of rec-myc cells is post-mitotic and not predicted by the time after irradiation or behaviour of sister cells
50. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death
51. Molecular thanatopsis: A discourse on the BCL-2 family
52. Expression of insulin-like growth factor (IGF)-II and IGF-I receptor during proliferation and differentiation of Caco-2 human colon carcinoma cells
53. Constitutive insulin-like growth factor-II expression interferes with the enterocyte-like differentiation of Caco-2 cells